Safety and efficacy of topical OCS-01 ophthalmic suspension for the treatment of diabetic macular oedema: stage 1 of a multicentre, double-blind, randomised, vehicle-controlled phase 2/3 trial. (PubMed, EClinicalMedicine) - Aug 8, 2026 - P2/3 | "The dosing regimen was found to be appropriate for use in Stage 2, which will provide longer-term data. Oculis Sàrl, Lausanne, Switzerland."
Journal • P2/3 data • Cardiovascular • Diabetic Macular Edema • Macular Edema • Ophthalmology
|
|
Arshad M Khanani; David S Boyer; Hani Salehi-Had; Ramin Tadayoni; Sabri Markabi; Sunil Patel
|